Birmingham Research and Development

Birmingham Research and Development Limited (BRDL), operating as University of Birmingham Enterprise, is the commercial arm of the University of Birmingham, dedicated to translating academic research into commercial success. The company manages the university's extensive intellectual property portfolio, with a particular emphasis on life sciences, medical technology, and healthcare innovations. BRDL facilitates the formation of spin-out companies and negotiates licensing agreements with industry partners to bring novel therapeutics, diagnostics, and medical devices to market. Its portfolio includes diverse assets such as viral-inhibiting nasal sprays, advanced diagnostic platforms, and next-generation cancer therapies. Additionally, BRDL manages the Birmingham Research Park, providing essential infrastructure and support for the regional biotech ecosystem. The organization serves as a vital link between laboratory-based discovery and clinical application, driving economic and health impacts.